Farma

rischioso
26.08.2020 kl 00:41 2672

En meget interessant artikkel om nytt funn som virker å øke sannsynligheten for at Bemcentinib vil kunne bidra i kampen om å få frem en Covid-19 behandling.

-----------------------------

Studie avdekker immunsystemavvik i alvorlige COVID-19 tilfeller

Three molecular suspects

The researchers analyzed the immune response in 76 people with COVID-19 and in 69 healthy people. They found enhanced levels of molecules that promote inflammation in the blood of severely ill COVID-19 patients.

"Three of the molecules they identified have been shown to be associated with lung inflammation in other diseases but had not been shown previously in COVID-19 infections"

These three molecules and their receptors could represent attractive therapeutic targets in combating COVID-19,” said Pulendran, who is the Violetta L. Horton Professor. His lab is now testing the therapeutic potential of blocking these molecules in animal models of COVID-19.

http://med.stanford.edu/news/all-news/2020/08/immune-system-deviations-found-in-severe-covid-19-cases.html

Redigert 26.08.2020 kl 01:07

Rapportér innlegg

Vennligst skriv inn kommentar på hva du mener er upassende og trykk send. Dersom kommentar ikke er nødvendig, vennligst trykk send direkte.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.
E-postadressen brukes kun for å få kontakt med deg i forbindelse med advarselen.